WEBSITE BSE:507794 NSE : KHAITAN CHEM 21 Apr, 09:49
Market Cap ₹508 Cr.
Stock P/E -7.2
P/B 2.4
Current Price ₹52.4
Book Value ₹ 22
Face Value 1
52W High ₹99.7
Dividend Yield 0%
52W Low ₹ 44.4
Khaitan Chemicals and Fertilizers Ltd manufactures and sells single super phosphate (SSP), sulphuric acid, and other chemical compounds in India. It operates through 3 segments: Fertilizer and Chemicals, Agri (Soya), and Others. The organisation gives plain, zincated, and boronated SSP fertilizers in powder and granulated forms underneath the Khaitan SSP and Utsav SSP manufacturers to be used in crops, consisting of oil seeds, groundnuts, potatoes, and so forth. It additionally produces sulphuric acid, which is utilized in manufacturing of SSP fertilizers, copper sulphate, zinc sulphate, ferrous sulphate, and health medicines; sulphur trioxide and oleum which can be used for the manufacturing of plastics, detergents, and dyestuffs; and linier alkyl benzene sulphonic acid, that's used to provide detergent and cake for washing the clothes. In addition, the business enterprise manufactures and sells crude soya oil and de-oiled cakes; and refined vegetable oil under the Khaitan Vegetable Oil brand. Further, it generates steam and sells wind power. The company turned into integrated in 1982 and is based in Indore, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 277 | 214 | 182 | 164 | 193 | 127 | 51 | 130 | 231 | 199 |
Other Income | 1 | 0 | 1 | 0 | 1 | 1 | -0 | 0 | 0 | 0 |
Total Income | 277 | 214 | 182 | 164 | 194 | 128 | 51 | 130 | 231 | 199 |
Total Expenditure | 245 | 200 | 165 | 163 | 183 | 142 | 78 | 137 | 222 | 188 |
Operating Profit | 32 | 13 | 18 | 1 | 11 | -14 | -28 | -7 | 9 | 11 |
Interest | 6 | 5 | 5 | 7 | 8 | 9 | 9 | 7 | 8 | 7 |
Depreciation | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 24 | 6 | 11 | -8 | 1 | -25 | -39 | -17 | -2 | 1 |
Provision for Tax | 7 | 2 | 3 | -2 | 0 | 2 | -2 | 0 | 1 | -12 |
Profit After Tax | 17 | 5 | 7 | -7 | 0 | -27 | -37 | -17 | -3 | 13 |
Adjustments | 0 | 3 | 2 | 1 | 0 | 0 | -0 | -0 | 0 | 0 |
Profit After Adjustments | 17 | 8 | 10 | -6 | 0 | -27 | -37 | -17 | -3 | 13 |
Adjusted Earnings Per Share | 1.8 | 0.5 | 0.8 | -0.7 | 0 | -2.8 | -3.9 | -1.7 | -0.3 | 1.3 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 388 | 329 | 392 | 359 | 353 | 373 | 437 | 481 | 824 | 888 | 536 | 611 |
Other Income | 9 | 3 | 2 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 0 |
Total Income | 397 | 332 | 394 | 362 | 355 | 373 | 439 | 481 | 825 | 889 | 537 | 611 |
Total Expenditure | 370 | 295 | 352 | 320 | 317 | 330 | 391 | 419 | 702 | 810 | 566 | 625 |
Operating Profit | 27 | 37 | 42 | 42 | 38 | 44 | 48 | 62 | 123 | 80 | -29 | -15 |
Interest | 25 | 30 | 30 | 31 | 26 | 22 | 18 | 14 | 13 | 20 | 32 | 31 |
Depreciation | 8 | 9 | 9 | 8 | 9 | 9 | 9 | 7 | 7 | 9 | 12 | 12 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -6 | -2 | 3 | 2 | 2 | 13 | 22 | 42 | 103 | 51 | -72 | -57 |
Provision for Tax | -5 | -5 | 2 | 0 | 1 | 5 | 6 | 15 | 23 | 14 | -1 | -13 |
Profit After Tax | -2 | 4 | 2 | 2 | 2 | 8 | 15 | 27 | 80 | 37 | -70 | -44 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -1 | 5 | 0 | 0 |
Profit After Adjustments | -2 | 4 | 2 | 2 | 2 | 8 | 15 | 25 | 79 | 42 | -70 | -44 |
Adjusted Earnings Per Share | -0.2 | 0.4 | 0.2 | 0.2 | 0.2 | 0.8 | 1.6 | 2.8 | 8.3 | 3.9 | -7.3 | -4.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -40% | 4% | 8% | 3% |
Operating Profit CAGR | -136% | NAN% | NAN% | NAN% |
PAT CAGR | -289% | NAN% | NAN% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -29% | -29% | 52% | 21% |
ROE Average | -27% | 8% | 10% | 6% |
ROCE Average | -8% | 15% | 16% | 12% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 125 | 126 | 127 | 129 | 130 | 138 | 153 | 174 | 252 | 294 | 220 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 20 | 21 | 52 | 49 | 42 | 31 | 19 | 19 | 7 | 24 | 17 |
Other Non-Current Liabilities | 10 | 5 | 5 | 5 | 5 | 8 | 12 | 17 | 18 | 17 | 16 |
Total Current Liabilities | 231 | 247 | 216 | 254 | 213 | 176 | 206 | 144 | 293 | 368 | 370 |
Total Liabilities | 386 | 399 | 400 | 438 | 391 | 353 | 391 | 354 | 571 | 707 | 623 |
Fixed Assets | 123 | 124 | 118 | 118 | 114 | 108 | 102 | 100 | 102 | 129 | 132 |
Other Non-Current Assets | 7 | 3 | 5 | 8 | 6 | 6 | 6 | 6 | 23 | 17 | 10 |
Total Current Assets | 257 | 272 | 277 | 312 | 271 | 240 | 282 | 249 | 440 | 558 | 481 |
Total Assets | 386 | 399 | 400 | 438 | 391 | 353 | 391 | 354 | 571 | 707 | 623 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 |
Cash Flow from Operating Activities | 175 | 21 | 26 | 32 | 64 | 92 | 16 | 84 | 27 | -88 | -55 |
Cash Flow from Investing Activities | -23 | -8 | -2 | -9 | 0 | -4 | 1 | -6 | -20 | -22 | 2 |
Cash Flow from Financing Activities | -151 | -13 | -24 | -23 | -65 | -88 | -17 | -79 | 40 | 63 | 53 |
Net Cash Inflow / Outflow | 1 | 0 | -1 | -0 | -0 | 0 | 0 | -0 | 47 | -47 | -0 |
Closing Cash & Cash Equivalent | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 0 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -0.17 | 0.36 | 0.17 | 0.17 | 0.17 | 0.81 | 1.55 | 2.78 | 8.27 | 3.85 | -7.27 |
CEPS(Rs) | 0.62 | 1.28 | 1.06 | 1.02 | 1.07 | 1.72 | 2.43 | 3.46 | 9.02 | 4.79 | -6.08 |
DPS(Rs) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.2 | 0.25 | 0.3 | 0.3 | 0 |
Book NAV/Share(Rs) | 12.88 | 13.01 | 13.12 | 13.31 | 13.44 | 14.24 | 15.78 | 17.96 | 26.01 | 30.29 | 22.73 |
Core EBITDA Margin(%) | 4.52 | 10.36 | 10.07 | 10.49 | 10.18 | 11.49 | 10.57 | 12.77 | 14.77 | 8.82 | -5.61 |
EBIT Margin(%) | 4.8 | 8.53 | 8.32 | 9.14 | 8.13 | 9.34 | 9.14 | 11.51 | 14.03 | 7.97 | -7.47 |
Pre Tax Margin(%) | -1.57 | -0.5 | 0.84 | 0.58 | 0.68 | 3.37 | 4.93 | 8.69 | 12.49 | 5.75 | -13.41 |
PAT Margin (%) | -0.41 | 1.05 | 0.42 | 0.45 | 0.46 | 2.12 | 3.45 | 5.6 | 9.73 | 4.21 | -13.15 |
Cash Profit Margin (%) | 1.53 | 3.71 | 2.59 | 2.71 | 2.92 | 4.47 | 5.4 | 6.97 | 10.62 | 5.23 | -11.01 |
ROA(%) | -0.37 | 0.89 | 0.42 | 0.4 | 0.4 | 2.12 | 4.06 | 7.23 | 17.33 | 5.85 | -10.6 |
ROE(%) | -1.29 | 2.79 | 1.31 | 1.29 | 1.27 | 5.88 | 10.36 | 16.47 | 37.6 | 13.68 | -27.41 |
ROCE(%) | 4.82 | 8.27 | 9.32 | 9.16 | 8.24 | 11.47 | 14.09 | 20.33 | 36.09 | 15.67 | -7.67 |
Receivable days | 47.99 | 55.83 | 68.17 | 92.61 | 97.84 | 77.21 | 46.99 | 36.87 | 18.09 | 21.19 | 38.84 |
Inventory Days | 147.86 | 145.74 | 91.16 | 83.12 | 90.33 | 80.22 | 84.25 | 85.43 | 71.21 | 94.84 | 182.19 |
Payable days | 37.38 | 48.45 | 37.79 | 56.61 | 66.36 | 73.96 | 72.84 | 68.75 | 55.22 | 68.24 | 76.97 |
PER(x) | 0 | 18.82 | 46.84 | 93.33 | 75.9 | 9.9 | 3.52 | 7.92 | 15.24 | 17.39 | 0 |
Price/Book(x) | 0.5 | 0.52 | 0.61 | 1.2 | 0.96 | 0.57 | 0.35 | 1.22 | 4.84 | 2.21 | 2.83 |
Dividend Yield(%) | 0.78 | 0.74 | 0.63 | 0.31 | 0.39 | 0.62 | 3.65 | 1.14 | 0.24 | 0.45 | 0 |
EV/Net Sales(x) | 0.68 | 0.85 | 0.77 | 1.08 | 0.91 | 0.56 | 0.43 | 0.59 | 1.58 | 0.96 | 1.73 |
EV/Core EBITDA(x) | 10 | 7.51 | 7.2 | 9.29 | 8.56 | 4.78 | 3.85 | 4.61 | 10.56 | 10.71 | -32.55 |
Net Sales Growth(%) | -15.32 | -15.16 | 19.16 | -8.57 | -1.53 | 5.48 | 17.31 | 10 | 71.32 | 7.77 | -39.64 |
EBIT Growth(%) | -31.67 | 50.98 | 16.16 | 0.62 | -13.37 | 20.68 | 14.76 | 38.53 | 108.83 | -38.82 | -156.62 |
PAT Growth(%) | -176.23 | 315.79 | -52.72 | 0.05 | -0.93 | 380.9 | 90.96 | 78.68 | 197.52 | -53.4 | -288.69 |
EPS Growth(%) | -176.23 | 315.83 | -52.73 | 0.06 | -0.94 | 380.98 | 90.95 | 78.68 | 197.52 | -53.4 | -288.69 |
Debt/Equity(x) | 1.7 | 1.79 | 1.82 | 1.85 | 1.55 | 0.99 | 0.91 | 0.45 | 0.54 | 0.75 | 1.4 |
Current Ratio(x) | 1.11 | 1.1 | 1.28 | 1.23 | 1.27 | 1.36 | 1.37 | 1.73 | 1.5 | 1.51 | 1.3 |
Quick Ratio(x) | 0.53 | 0.56 | 0.98 | 0.83 | 0.92 | 0.86 | 0.82 | 0.95 | 0.79 | 0.83 | 0.54 |
Interest Cover(x) | 0.75 | 0.94 | 1.11 | 1.07 | 1.09 | 1.57 | 2.17 | 4.07 | 9.1 | 3.59 | -1.26 |
Total Debt/Mcap(x) | 3.4 | 3.42 | 2.99 | 1.55 | 1.62 | 1.75 | 2.61 | 0.37 | 0.11 | 0.34 | 0.5 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 74.99 | 72.52 | 72.52 | 72.52 |
FII | 0 | 0 | 0 | 0.01 | 0.11 | 0.02 | 0.09 | 0.08 | 0.08 | 0.16 |
DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Public | 24.99 | 25 | 25 | 24.99 | 24.89 | 24.98 | 24.9 | 27.39 | 27.39 | 27.31 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 7.27 | 7.27 | 7.27 | 7.27 | 7.27 | 7.27 | 7.27 | 7.03 | 7.03 | 7.03 |
FII | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.02 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 2.42 | 2.42 | 2.42 | 2.42 | 2.41 | 2.42 | 2.42 | 2.66 | 2.66 | 2.65 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About